Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 47 citing articles:

Diabetes and restenosis
Scott Wilson, Pasquale Mone, Urna Kansakar, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine
Huiling Tan, Yue Tong, Zhengfang Chen, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 66-88
Open Access | Times Cited: 48
Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence
Luigi Barrea, Massimiliano Caprio, Mikiko Watanabe, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 26, pp. 8320-8336
Closed Access | Times Cited: 43
The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity
Roberta Rinaldi, Sara De Nucci, Fabio Castellana, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 825-825
Open Access | Times Cited: 27
Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review
Mikiko Watanabe, Renata Risi, Davide Masi, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2873-2873
Open Access | Times Cited: 68
Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine
Mikiko Watanabe, Angela Balena, Davide Masi, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 79-79
Open Access | Times Cited: 34
Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial
Catarina Lindqvist, Magnus Holmer, Hannes Hagström, et al.
Nutrition (2023) Vol. 110, pp. 111982-111982
Open Access | Times Cited: 16
Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 874-874
Open Access | Times Cited: 6
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4857-4857
Open Access | Times Cited: 6
Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting
Elena Tragni, Luisella Vigna, Massimiliano Ruscica, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1804-1804
Open Access | Times Cited: 35
Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis
Renata Risi, Giovanni Rossini, Rossella Tozzi, et al.
Surgery for Obesity and Related Diseases (2022) Vol. 18, Iss. 7, pp. 983-996
Closed Access | Times Cited: 27
Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21
Eun Ran Kim, So Ra Kim, Wonhee Cho, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Fibroblast growth factor 21 in metabolic syndrome
Ming Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
Rocío Gallego‐Durán, Javier Ampuero, Douglas Maya‐Miles, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 8, pp. 1056-1068
Open Access | Times Cited: 5
Supplement for controlling blood lipids and maintaining anthropometric indicators in obese women: Zinc or Lactobacillus casei ‎
Rusli Rusli, Rudy Hartono, Mira Andini, et al.
Journal Of Advanced Pharmacy Education And Research (2025) Vol. 15, Iss. 1, pp. 35-42
Closed Access
Advancing Obesity Management: the Very Low-Energy Ketogenic therapy (VLEKT) as an Evolution of the “Traditional” Ketogenic Diet
Francesco Balestra, Maria De Luca, G. Panzetta, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access
Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health
Fabrizio Emanuele, Mattia Biondo, Laura Tomasello, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1269-1269
Open Access
Preclinical evidence construction for epigallocatechin-3-gallate against non-alcoholic fatty liver disease: a meta-analysis and machine learning study
Yuanhao Zhang, Jianguo Li, Zexin Wang, et al.
Phytomedicine (2025), pp. 156651-156651
Closed Access
Liver disease in obesity and underweight: the two sides of the coin. A narrative review
Renata Risi, Dario Tuccinardi, Stefania Mariani, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2020) Vol. 26, Iss. 7, pp. 2097-2107
Closed Access | Times Cited: 28
The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?
Zahra Ilyas, Simone Perna, Tariq A. Alalwan, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 620-620
Open Access | Times Cited: 18
Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice
Danfeng Lin, Qiyan Sun, Zhaoyang Liu, et al.
Free Radical Biology and Medicine (2022) Vol. 195, pp. 199-218
Closed Access | Times Cited: 18
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet
Ilaria Ernesti, Francesco Baratta, Mikiko Watanabe, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 8
Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction
Renata Risi, Rossella Tozzi, Mikiko Watanabe
Current Opinion in Clinical Nutrition & Metabolic Care (2021) Vol. 24, Iss. 4, pp. 349-353
Closed Access | Times Cited: 16
Application of a Machine Learning Technology in the Definition of Metabolically Healthy and Unhealthy Status: A Retrospective Study of 2567 Subjects Suffering from Obesity with or without Metabolic Syndrome
Davide Masi, Renata Risi, Filippo Biagi, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 373-373
Open Access | Times Cited: 12
Very Low-Carbohydrate High-Fat Diet Improves Risk Markers for Cardiometabolic Health More Than Exercise in Men and Women With Overfat Constitution: Secondary Analysis of a Randomized Controlled Clinical Trial
Lukáš Cipryan, Martina Litschmannová, Philip Maffetone, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top